Stay updated on Mepolizumab for COPD Hospital Eosinophilic Admissions Clinical Trial

Sign up to get notified when there's something new on the Mepolizumab for COPD Hospital Eosinophilic Admissions Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mepolizumab for COPD Hospital Eosinophilic Admissions Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3, indicating a minor update to the page version of the study record. This change signals maintenance updates rather than alterations to study data displayed.
    Difference
    0.0%
    Check dated 2026-07-05T14:21:01.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.0 to v3.6.2, indicating a minor version update to the site's framework with no changes to the displayed study details.
    Difference
    0.0%
    Check dated 2026-06-28T08:25:03.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The page now indicates recruitment status explicitly and adds user guidance sections along with an updated header and a revision note, clarifying how to read the study record and how to join the study.
    Difference
    0.4%
    Check dated 2026-06-14T05:45:36.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.5.5 was added, replacing the previous v3.5.4 on the page. This appears to be an administrative update to the page version and does not modify the study data or user-facing content.
    Difference
    0.1%
    Check dated 2026-06-07T02:12:48.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added and the previous Revision: v3.5.3 was removed, updating the page's version metadata.
    Difference
    0.1%
    Check dated 2026-05-16T09:18:52.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    This update corresponds to the study’s **results being posted (2026-04-24)** and revises/defines key **outcome measure details**—notably the timing and definitions of endpoints such as **time to hospital readmission or death (all-cause and respiratory-cause)**, **treatment failure**, and counts of hospital readmissions and exacerbations over the **48-week** period. It also updates the specification of several measured patient outcomes (e.g., questionnaire-based health status scales such as eMRC/WEMWBS/SPPB/LCADL, oxygen/inflammatory marker outcomes, and continuous measures including temperature and heart rate across the follow-up window).
    Difference
    5%
    Check dated 2026-04-24T22:20:19.000Z thumbnail image

Stay in the know with updates to Mepolizumab for COPD Hospital Eosinophilic Admissions Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mepolizumab for COPD Hospital Eosinophilic Admissions Clinical Trial page.